Clinical trials: Spotting

Metrorrhagia

Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding

• Completed
• Age: 18 years and older
• Phase 3
• Results posted

The purpose of this study is to determine whether the study drug is safe and effective in the treatment of dysfunctional uterine bleeding.

Trial name

NCT00307801

Testing

Estradiol valerate/Dienogest (Natazia, Qlaira, BAY86-5027)

Where

36 sites in Australia, Czechia and 8 more

Volunteers

231 people

Sponsor

Bayer